Evidence map›Paper›PMID 32705537›Full record

ArticleClinical journal of gastroenterology2020

A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography.

Shinichi Akahoshi, Kensuke Yamamura, Nobutaka Sato, Eri Oda, Koichi Kinoshita, Hideaki Yuki, Toshihiko Motohara, Akihiro Deguchi, Yoshihiro Komohara, Toru Beppu

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shinichi AkahoshiDepartment of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan. r-star1@hotmail.co.jp.ORCID http://orcid.org/0000-0001-9347-363X
Kensuke YamamuraDepartment of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.
Nobutaka SatoDepartment of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.
Eri OdaDepartment of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.
Koichi KinoshitaDepartment of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.
Hideaki YukiDepartment of Radiology, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.
Toshihiko MotoharaDepartment of Gastroenterology, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.
Akihiro DeguchiDepartment of Internal Medicine, Kagawa Rosai Hospital, 3-3-1 Jyoto, Marugame, Kagawa, 763‑8502, Japan.
Yoshihiro KomoharaDepartment of Cell Pathology, Graduate School of Life Sciences, Kumamoto University, 1-1-1, honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Toru BeppuDepartment of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.
Sunagawa City Medical Center · JPKumamoto University · JPYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic sclerosed hemangioma is a rare benign liver tumor that originated from hepatic cavernous hemangioma; however, the process of its formation has been unclear. We herein present the patient of a histologically proven hepatic sclerosed hemangioma that showed drastic changes in diagnostic images in a short period. A 56-year-old man was referred to our hospital for the treatment of suspicious hepatocellular carcinoma with hepatitis C, approximately 2 cm in diameter in liver segment 8. Initially, the tumor manifested as early entire enhancement with mildly delayed washout in contrast-enhanced ultrasonography; however, it manifested as continuous peripheral enhancement with the central non-enhanced area after 1 month in various diagnostic images. He completely quit drinking and smoking 1 month preoperatively. No special symptoms and signs were found to suggest tumor ischemia. Anatomical resection of segment 8 was completed. Histological examination confirmed the final diagnosis of common type hepatic sclerosed hemangioma, derived from atypically enhancing cavernous hemangioma. No signs of impaired blood flow were observed in both diagnostic images and histological examination. Sclerosing changes in hepatic cavernous hemangioma may be completed in a relatively short time with no apparent reason.

Indexed as

Carcinoma, HepatocellularHemangiomaHemangioma, CavernousLiver NeoplasmsHumansMaleMiddle AgedUltrasonographyAtypical hepatic cavernous hemangiomaContrast-enhanced ultrasonographyHepatic sclerosed hemangioma

Identifiers

PMID32705537
OpenAlexW3045425103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.